Research

OSC and Ohio Medical Research Centers Receive Federal Funds for Pediatric Cancer Research

The Ohio Supercomputer Center (OSC), along with three state medical centers, has received $350,000 for pediatric cancer research as part of the federal FY2004 Omnibus Appropriations bill.

This grant will be used to apply new techniques developed at the National Cancer Institute's Advanced Biomedical Computing Center (NCI-ABCC) to the study of children's diseases. Research results will accelerate the insight and understanding of cancer, leading to improved diagnostics, treatments and even new prevention options.

OSU chemist developing solution to nerve agent exposure

Scientists are working to develop a new drug that will regenerate a critical enzyme in the human body that “ages” after a person is exposed to deadly chemical warfare agents.

Christopher Hadad, Ph.D., professor of chemistry at The Ohio State University (OSU), is leveraging Ohio Supercomputer Center (OSC) resources to help develop a more effective antidote to lethal chemicals called organophosphorus (OP) nerve agents.

Pages